defect

(redirected from atrial septal defects)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

defect

Crystallog a local deviation from regularity in the crystal lattice of a solid

Defect

In lumber, an irregularity occurring in or on wood that will tend to impair its strength, durability, or utility value.

defect

[′dē‚fekt]
(science and technology)
An irregularity that spoils the appearance or impairs the usefulness or effectiveness of an object or a material by causing weakness or failure.

defect

In wood, a fault that may reduce its durability, usefulness, or strength.

defect

References in periodicals archive ?
Does it matter if atrial septal defects are not diagnosed in childhood?
55) have not found clear genotype-phenotype correlation among 10 mutations located in NK homeodomain in familial atrial septal defect.
In the first study, 89 adults being assessed after cryptogenic stroke were found to have patent foramen ovale (PFO) (66 subjects) or atrial septal defects (23 subjects).
Food and Drug Administration approved the first device for closing atrial septal defects in children in 2001.
Babies of smokers were 56% more likely to be born with atrial septal defects, tetralogy of Fallot, valvular abnormalities, or another cardiovascular anomaly.
Among patients who have a large defect, Eisenmenger syndrome develops in nearly all patients with truncus arteriosus, about half of those with ventricular septal defects or patent arterial ducts, and only in about 10% of those with atrial septal defects (3).
court has determined that an AGA-held patent for its Atrial Septal Defects (ASD) and Patent Foramen Ovale (PFO) devices is valid.
In December 2001 the FDA approved the AMPLATZER(R) Septal Occluder for treating atrial septal defects, present in about 10 percent of congenital heart defect patients.
Clinical outcomes and costs of Amplatzer transcatheter closure as compared with surgical closure of ostium secundum atrial septal defects.
Nasdaq: NMTI) today announced the completion of device implants in its clinical trial for use of the CardioSEAL(TM) Septal Occlusion System for the treatment of atrial septal defects (ASDs).